--- title: Buy Vaniqa (Eflornithine) 13.9% Cream Tube description: Vaniqa (Eflornithine) cream reduces unwanted facial hair growth in women. Order this prescription treatment from our trusted online pharmacy for visible results. type: product language: en url: https://liabilis.com/order-vaniqa-online-en.html availability: in_stock shipping: - type: Standard Airmail price: 10.00 currency: USD area: Worldwide time: 14-21 days - type: Tracked Express price: 30.00 currency: USD area: Worldwide tracking: true time: 5-9 days price_min: 74.09 price_max: 173.99 currency: USD offers: - name: 13.9% x 1 tube price: 74.09 - name: 13.9% x 2 tubes price: 126.34 - name: 13.9% x 3 tubes price: 173.99 --- # Buy Vaniqa (Eflornithine) 13.9% Cream Tube Vaniqa contains the active ingredient Eflornithine and is a topical cream that slows unwanted facial hair growth in women. Originally developed by Bristol-Myers Squibb, this prescription treatment works by inhibiting an enzyme necessary for hair growth, resulting in finer and less noticeable hair over time. It is designed for women seeking to manage excessive facial hair without frequent shaving or waxing. Our pharmacy offers Vaniqa in a convenient 13.9% cream tube formulation for effective hair reduction treatment. ## Pricing and Options | Dosage | Pack Size | Price (USD) | Price Per Pill | Status | | :--- | :--- | :--- | :--- | :--- | | **13.9%** | 1 tube | **$74.09** | $74.09 | In Stock | | **13.9%** | 2 tubes | **$126.34** | $63.17 | In Stock | | **13.9%** | 3 tubes | **$173.99** | $58.00 | In Stock | [Buy Now](https://liabilis.com/order-vaniqa-online-en.html) ## Introduction Vaniqa is a topical medication used to reduce the growth of unwanted facial hair in adult women. Its active ingredient is eflornithine, a reversible inhibitor of the enzyme ornithine decarboxylase. Vaniqa is supplied as a 13.9 % eflornithine cream in a tube for once-daily application to the affected facial areas. The product belongs to the class of topical anti-hair-growth agents. In addition to its primary indication, clinicians sometimes consider Vaniqa for other forms of excessive hair growth, although such uses are not officially approved. ## Quick Reference Facts **Active Ingredient** : Eflornithine **Form** : Tube, 13.9 % cream **Primary Uses** : Reduction of unwanted facial hair (peach-fuzz) in adult women ## What is Vaniqa? Vaniqa is the generic version of medications containing the active compound eflornithine. It is marketed under brand names such as Vaniqa and other regional equivalents. The formulation is a 13.9 % eflornithine hydrochloride cream designed for topical use on the face. The product was developed by a collaboration of dermatology researchers and is approved by regulatory agencies in multiple jurisdictions for the treatment of unwanted facial hair in women. Because it is a generic preparation, Vaniqa offers the same therapeutic effect as the branded versions while typically providing cost savings for patients. ## How Vaniqa Works Eflornithine inhibits ornithine decarboxylase, an enzyme that catalyzes the conversion of ornithine to putrescine, a key step in polyamine synthesis. Polyamines are essential for cell proliferation, including the rapidly dividing keratinocytes of the hair follicle matrix. By reducing polyamine production, eflornithine slows the mitotic activity of hair follicle cells, leading to a gradual decrease in hair shaft emergence. The inhibition is reversible; normal hair growth resumes when treatment is discontinued. After application, the cream is absorbed into the superficial epidermis, with minimal systemic exposure, which accounts for its favorable safety profile. Clinical observations indicate that visible hair reduction typically becomes noticeable after 4-8 weeks of consistent daily use. ## Conditions Treated with Vaniqa - **Unwanted facial hair in adult women** - Vaniqa is approved to diminish the appearance of fine, unwanted hair (often called “peach-fuzz”) on the face. The topical action slows new hair growth, making existing hairs less noticeable and easier to remove by other methods. - **Post-laser or electrolysis maintenance** - Although not an official indication, dermatologists sometimes advise continued Vaniqa use after laser hair-removal procedures to prolong the period between sessions. The drug helps maintain the reduced-growth state achieved by the energy-based treatment. ## Is Vaniqa the Right Medication for You? Vaniqa is most suitable for adult women who are troubled by fine facial hairs that are resistant to conventional cosmetic removal methods. Ideal candidates have healthy skin without active dermatitis, eczema, or open wounds in the treatment area. It is particularly advantageous for individuals seeking a non-invasive, daily regimen that can be combined with other hair-removal techniques. Contraindications include known hypersensitivity to eflornithine or any excipients in the cream, active facial infections, and pregnancy or breastfeeding, as safety has not been established in these populations. Patients with severe skin disorders (e.g., severe psoriasis) should discuss alternatives with a dermatologist, as irritation may be amplified. ## Buying Vaniqa from [our online pharmacy](https://liabilis.com/order-vaniqa-online-en.html) ### Why Choose Our Service? Accessing Vaniqa can be challenging due to limited pharmacy stock or high retail prices. Our platform provides a convenient way to obtain the medication at a price close to the manufacturer’s cost, alleviating the financial burden for many patients. ### Quality & Safety Assurance We partner with licensed international pharmacies to ensure quality and authenticity. Every batch of Vaniqa is sourced from certified suppliers who comply with recognized regulatory frameworks, guaranteeing that you receive a product that meets stringent safety standards. ### Pricing & Access Because Vaniqa is a generic formulation, it is offered at a fraction of the price of branded alternatives. Our pharmacy service makes the medication reachable for individuals who may otherwise face prohibitive out-of-pocket expenses or geographic scarcity. ### Discreet Delivery Your order arrives in unmarked packaging, preserving privacy. Express delivery typically reaches you within 7 days, while standard airmail arrives in approximately 3 weeks, ensuring a reliable and confidential supply chain. ## Use: Dosing, Missed Dose, Overdose **Standard Dosing** - Apply a thin layer of the 13.9 % eflornithine cream to the desired facial area once daily, preferably in the evening after cleansing. - Use the supplied applicator tip to spread the cream evenly; avoid the eyes, mouth, and mucous membranes. **Missed Dose** - If you forget a dose, apply it as soon as you remember unless it is within 12 hours of the next scheduled dose. In that case, skip the missed application and resume the regular schedule. **Overdose** - Because systemic absorption is minimal, overdose is unlikely. Nevertheless, if a large amount is applied inadvertently, rinse the area thoroughly with water and seek medical advice if irritation persists. **Practical Precautions** - Do not combine Vaniqa with other topical irritants (e.g., retinoids, abrasive scrubs) on the same day. - Alcohol consumption does not affect the medication, but avoid operating heavy machinery if the cream causes transient visual irritation near the eyes. ## Safety Information ### ⚠️ Who Should Not Take Vaniqa - Individuals with a documented allergy to eflornithine or any cream component. - Pregnant or breastfeeding women, due to insufficient safety data. - Patients with active facial infections, open wounds, or severe dermatologic conditions in the treatment area. ### Common Side Effects - **Skin irritation** (burning, stinging, or tingling) - occurs in up to 20 % of users; generally mild and diminishes with continued use. - **Erythema or redness** - localized reddening is common, especially during the first weeks. - **Dryness or flaking** - moisturizers may be used, provided they do not contain alcohol or exfoliating acids. ### Serious Side Effects (Seek Immediate Medical Help) - **Severe allergic reaction** (swelling of the face, lips, tongue, or difficulty breathing). - **Extensive blistering or ulceration** of the skin. - **Persistent, worsening rash** that does not improve after a few days of discontinuation. If any of these occur, discontinue use and contact a healthcare professional promptly. ### Drug & Food Interactions - **Topical retinoids or benzoyl peroxide** - can increase skin irritation; use on alternate days if both are required. - **Photosensitizing agents** (e.g., certain antibiotics, herbal supplements) - may enhance sun sensitivity; employ sunscreen with SPF 30+ when outdoors. - **Oral medications** - systemic interactions are negligible due to minimal absorption, but always inform your clinician of all concurrent drugs. ## Off-Label and Investigational Uses of Vaniqa - **Male facial hirsutism** - Small case series have explored topical eflornithine for men with excessive facial hair, reporting modest reductions. Formal approval is lacking, and treatment should only be considered under specialist supervision. - **Body hair reduction** - Investigational studies have applied the cream to the chest and abdomen, noting limited efficacy compared with facial hair, likely due to differences in follicle density. - **Adjunct to laser therapy** - Some dermatologists use Vaniqa before and after laser hair removal to prolong remission periods; evidence suggests a possible synergistic effect, though larger trials are needed. All off-label applications remain experimental, and patients should discuss potential risks and benefits with a qualified provider. ## Storage & Handling - Store the tube at controlled room temperature (15 °C-30 °C). - Keep the product away from direct sunlight and excessive humidity. - Close the cap tightly after each use to maintain stability. - Discard any cream that has changed color, developed an off-odor, or is past the expiration date printed on the packaging. ## Frequently Asked Questions **Practical Use & Lifestyle** - **Can I apply Vaniqa before swimming or exercising?** Yes. Apply the cream at least 30 minutes before water exposure to allow absorption. Rinse gently after prolonged swimming to remove residual product. - **Will sunscreen affect Vaniqa’s efficacy?** No. Using a broad-spectrum sunscreen with SPF 30 or higher is recommended, as it protects the treated skin from UV-induced irritation without interfering with the cream’s action. - **Is it safe to use Vaniqa while taking oral contraceptives?** Oral contraceptives do not interact with topical eflornithine; they can be continued as prescribed. **Product & Formulation Details** - **What does the Vaniqa tube look like?** The tube is opaque white with a blue label indicating “13.9 % eflornithine cream.” The applicator tip is a small, rounded nozzle for precise dosing. - **Are there any preservatives in the cream?** The formulation contains a mild preservative system (phenoxyethanol and ethylhexylglycerin) to maintain product stability; these ingredients are listed in the package insert. - **Can the tube be shared with another person?** Sharing is not advised because the cream is prescribed for individual skin characteristics and to avoid cross-contamination. **Regulatory & Safety Nuances** - **Will Vaniqa show up on a standard drug test?** Because systemic absorption is minimal, Vaniqa does not appear in routine urine or blood drug screens. - **Is Vaniqa approved for use in males?** No. Regulatory agencies have approved Vaniqa solely for adult women with unwanted facial hair. Use in men is considered off-label. - **Can I travel internationally with Vaniqa?** Yes, but keep the medication in its original labeled container, carry a copy of the prescription or physician’s note, and be aware of the destination country’s import regulations for topical drugs. **Scientific & Clinical Curiosity** - **When was eflornithine first discovered?** Eflornithine was originally synthesized in the 197s for oncologic research and later repurposed for dermatologic use after observations of its anti-hair-growth properties. - **How does Vaniqa compare to older depilatory creams?** Unlike depilatory creams that chemically dissolve hair shafts, Vaniqa works at the follicular level to slow new hair formation, offering a longer-lasting reduction without immediate skin peeling. ## Glossary **Ornithine Decarboxylase** : An enzyme that catalyzes the first step in polyamine synthesis, essential for cell proliferation in hair follicles. **Polyamines** : Small organic compounds (e.g., putrescine, spermidine) that support DNA stabilization and cell growth; reduced levels lead to slower hair-follicle activity. **Reversible Inhibition** : A temporary blocking of enzyme activity that can be undone when the inhibitor is removed, allowing normal function to resume. ## Disclaimer The information provided about **Vaniqa** is for general knowledge only. It does not replace professional medical consultation. All treatment decisions, including those regarding off-label use, should be made under the supervision of a qualified healthcare provider. We assume all readers are responsible adults capable of making informed decisions about their health. [our online pharmacy](https://liabilis.com/order-vaniqa-online-en.html) offers access to **Vaniqa** for individuals who may have limited availability through traditional pharmacies, prescription-based insurance schemes, or who are seeking affordable generic alternatives. Always consult your doctor before starting, changing, or discontinuing any medication.